Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

6.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

148
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
148

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semi-Autonomic AI LF-NMR Sensor for Industrial Prediction of Edible Oil Oxidation Status.

Sensors (Basel, Switzerland)·2023
Same author

<sup>1</sup>H LF-NMR Self-Diffusion Measurements for Rapid Monitoring of an Edible Oil's Food Quality with Respect to Its Oxidation Status.

Molecules (Basel, Switzerland)·2022
Same author

Time Domain (TD) Proton NMR Analysis of the Oxidative Safety and Quality of Lipid-Rich Foods.

Biosensors·2022
Same author

Proton Low Field NMR Relaxation Time Domain Sensor for Monitoring of Oxidation Stability of PUFA-Rich Oils and Emulsion Products.

Foods (Basel, Switzerland)·2021
Same author

Characterization of Cationic Bolaamphiphile Vesicles for siRNA Delivery into Tumors and Brain.

Molecular therapy. Nucleic acids·2020
Same author

Maleimide-acetylcholine headed bolaamphiphilic vesicles made from ricinoleic acid: Prospective active targeted drug delivery systems.

Chemistry and physics of lipids·2018

Related Experiment Video

Updated: Apr 23, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.4K

Progress in lipid-based nanoparticles for cancer therapy.

Sarina Grinberg1, Charles Linder2, Eliahu Heldman3

  • 1Department of Chemistry, Ben-Gurion University of the Negev, Israel.

Critical Reviews in Oncogenesis
|October 2, 2014
PubMed
Summary

Novel nanotechnology-based drug delivery systems (DDS) offer improved cancer therapy by targeting tumors and reducing side effects. Lipid-based nanoparticles, especially bolaamphiphilic vesicles, show great promise for delivering therapeutic agents.

More Related Videos

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.7K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.2K

Related Experiment Videos

Last Updated: Apr 23, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.4K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.7K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.2K

Area of Science:

  • Nanomedicine
  • Biotechnology
  • Materials Science

Background:

  • Conventional cancer therapeutics exhibit limited tumor penetration and significant adverse effects, leading to low efficacy and high toxicity.
  • Novel drug delivery systems (DDS) aim to optimize drug concentration at malignant sites while minimizing systemic exposure.
  • Nanotechnology presents innovative solutions for overcoming challenges in cancer therapy.

Purpose of the Study:

  • To review the design principles of targeted DDS for cancer therapy.
  • To explore various types of nanoparticles currently under development for cancer treatment.
  • To highlight the potential of lipid-based nanoparticles, specifically bolaamphiphilic vesicles, in targeted drug and diagnostic agent delivery.

Main Methods:

  • Review of current literature on targeted drug delivery systems in cancer therapy.
  • Analysis of nanoparticle design considerations including targeting, controlled release, and barrier penetration.
  • Focus on lipid-based nanoparticles and bolaamphiphilic vesicles for systemic administration.

Main Results:

  • Nanoparticle-based DDS can enhance drug accumulation in tumors and reduce toxicity.
  • Design principles focus on achieving specific targeting, controlled drug release kinetics, and improved passage through biological barriers.
  • Bolaamphiphilic vesicles demonstrate significant potential for targeted delivery of therapeutic and diagnostic agents.

Conclusions:

  • Targeted DDS utilizing nanotechnology offer a promising strategy to improve cancer treatment efficacy and reduce patient toxicity.
  • Lipid-based nanoparticles, particularly bolaamphiphilic vesicles, are key candidates for advanced cancer nanomedicine.
  • Further development of these systems could revolutionize the delivery of both therapeutic and diagnostic agents in oncology.